GOT2 and pancreatic ductal adenocarcinoma: Previously, inhibition of glutamic oxaloacetic transaminase 2 (GOT2) has been shown to lead to elevated levels of reactive oxygen species (ROS) and cyclin‐dependent kinase inhibitor p27‐mediated cell senescence in human pancreatic ductal adenocarcinoma cells (Yang et al, 2018).